65 /100
HIGH RISK
Score updated Apr 13, 2026

RNA

Atrium Therapeutics, Inc. — Stock Dilution Tracker

Track RNA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track RNA — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
20
💰 Cash Runway
95
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
5%
📉 Score Deterioration 10%
• Score in HIGH risk zone (65/100)
🔔 Track RNA — Get forecast alerts →
💹 Market Data
Market Cap$197.20M
Shares Outstanding15.51M
Float15.04M
CashN/A
Debt$3.67M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 11.5% shares (2025Q4 vs prior)
346 institutional holders · 148.77M shares
#1 VANGUARD GROUP INC 13.65M shares
#2 BlackRock, Inc. 12.85M shares
#3 RA CAPITAL MANAGEMENT, L.P. 8.64M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.91M
Days to Cover2.9
% of Float12.7%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2021
xbrl XBRL CONVERTIBLE Dec 31, 2021
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track RNA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RNA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required